BRIEF-ALK Abelló: Marketing authorisation for Acarizax issued in France Jan 27 Alk Abello A/S :* Says that authorities in France have issued a marketing authorisation for ALK's new house dust mite sublingual allergy immuno-therapy tablet (slit-tablet), Acarizax Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Canadian energy companies sell "jewels" to keep oil sands afloat
Baltimore homicides top 300 for year, worst since 1999
FDA gives full approval to Amgen blood cancer drug